A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Pfizer Requests EUA to Administer its COVID-19 Vaccine to Kids


Pfizer has applied for Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) to administer its COVID-19 vaccination to children ages 5 to 11. The FDA has already granted full approval to the Pfizer COVID-19 vaccine when administered to adults. In September, Pfizer submitted the results of a large-scale clinical trial that showed the vaccine encouraged an effective antibody response with few side effects among kids 5 to 11. The FDA and its independent advisory committee will meet on October 26 to decide on whether to grant the EUA. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy